168 related articles for article (PubMed ID: 27585748)
21. Cholinesterase inhibitors modulate autonomic function in patients with Alzheimer´s disease and mixed dementia.
da Costa Dias FL; Ferreira Lisboa da Silva RM; de Moraes EN; Caramelli P
Curr Alzheimer Res; 2013 Jun; 10(5):476-81. PubMed ID: 23627707
[TBL] [Abstract][Full Text] [Related]
22. Improvement of nutritional status enhances cognitive and physical functions in older adults with orthostatic hypotension.
Kocyigit SE; Ates Bulut E; Aydin AE; Isik AT
Nutrition; 2021 Oct; 90():111261. PubMed ID: 33975062
[TBL] [Abstract][Full Text] [Related]
23. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
[TBL] [Abstract][Full Text] [Related]
24. Effects of Acetylcholinesterase Inhibitors on Nutritional Status in Elderly Patients with Dementia: A 6-month Follow-up Study.
Soysal P; Isik AT
J Nutr Health Aging; 2016 Apr; 20(4):398-403. PubMed ID: 26999239
[TBL] [Abstract][Full Text] [Related]
25. Blood pro-inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors.
Richardson C; Gard PR; Klugman A; Isaac M; Tabet N
Int J Geriatr Psychiatry; 2013 Dec; 28(12):1312-7. PubMed ID: 23585364
[TBL] [Abstract][Full Text] [Related]
26. The Relationship between the Most Common Subtypes of Dementia and Orthostatic Hypotension in Older Adults.
Isik AT; Kocyigit SE; Kaya D; Dost Gunay FS; Erken N; Dokuzlar O; Aydin AE; Ates Bulut E
Dement Geriatr Cogn Disord; 2020; 49(6):628-635. PubMed ID: 33735870
[TBL] [Abstract][Full Text] [Related]
27. Symptomatic orthostatic hypotension in Parkinson's disease patients: Prevalence, associated factors and its impact on balance confidence.
Klanbut S; Phattanarudee S; Wongwiwatthananukit S; Suthisisang C; Bhidayasiri R
J Neurol Sci; 2018 Feb; 385():168-174. PubMed ID: 29406900
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.
García-Alberca JM; Gris E; de la Guía P; Mendoza S; de la Rica ML
J Alzheimers Dis; 2023; 91(4):1459-1469. PubMed ID: 36641676
[TBL] [Abstract][Full Text] [Related]
29. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
Schreglmann SR; Büchele F; Sommerauer M; Epprecht L; Kägi G; Hägele-Link S; Götze O; Zimmerli L; Waldvogel D; Baumann CR
Eur J Neurol; 2017 Apr; 24(4):545-551. PubMed ID: 28224720
[TBL] [Abstract][Full Text] [Related]
30. Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis.
Mueller C; Perera G; Hayes RD; Shetty H; Stewart R
Age Ageing; 2018 Jan; 47(1):88-94. PubMed ID: 28655175
[TBL] [Abstract][Full Text] [Related]
31. Which is preferable for orthostatic hypotension diagnosis in older adults: active standing test or head-up tilt table test?
Aydin AE; Soysal P; Isik AT
Clin Interv Aging; 2017; 12():207-212. PubMed ID: 28182163
[TBL] [Abstract][Full Text] [Related]
32. Anti-dementia drugs and changes in gait: a pre-post quasi-experimental pilot study.
Beauchet O; Launay CP; Allali G; Watfa G; Gallouj K; Herrmann FR; Annweiler C
BMC Neurol; 2013 Nov; 13():184. PubMed ID: 24261605
[TBL] [Abstract][Full Text] [Related]
33. Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors.
Klugman A; Naughton DP; Isaac M; Shah I; Petroczi A; Tabet N
J Alzheimers Dis; 2012; 30(3):467-74. PubMed ID: 22451323
[TBL] [Abstract][Full Text] [Related]
34. Synthetic β-hydroxy ketone derivative inhibits cholinesterases, rescues oxidative stress and ameliorates cognitive deficits in 5XFAD mice model of AD.
Ahmad SI; Ali G; Muhammad T; Ullah R; Umar MN; Hashmi AN
Mol Biol Rep; 2020 Dec; 47(12):9553-9566. PubMed ID: 33211296
[TBL] [Abstract][Full Text] [Related]
35. Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment Ameliorate Acetaminophen-Induced Liver Injury in Mice via Central Cholinergic System Regulation.
Zhang J; Zhang L; Sun X; Yang Y; Kong L; Lu C; Lv G; Wang T; Wang H; Fu F
J Pharmacol Exp Ther; 2016 Nov; 359(2):374-382. PubMed ID: 27535978
[TBL] [Abstract][Full Text] [Related]
36. Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR cohort.
Gillette-Guyonnet S; Cortes F; Cantet C; Vellas B;
J Nutr Health Aging; 2005; 9(2):69-73. PubMed ID: 15791348
[TBL] [Abstract][Full Text] [Related]
37. Diminished Dynamic Physical Performance Is Associated With Orthostatic Hypotension in Geriatric Outpatients.
de Bruïne ES; Reijnierse EM; Trappenburg MC; Pasma JH; de Vries OJ; Meskers CGM; Maier AB
J Geriatr Phys Ther; 2019; 42(3):E28-E34. PubMed ID: 29578939
[TBL] [Abstract][Full Text] [Related]
38. [Scope and limitations of acetylcholinesterase inhibitors].
Sugimoto H
Nihon Yakurigaku Zasshi; 2004 Sep; 124(3):163-70. PubMed ID: 15333989
[TBL] [Abstract][Full Text] [Related]
39. Galantamine does not cause aggravated orthostatic hypotension in people with Alzheimer's disease.
van Beek AH; Sijbesma JC; Olde Rikkert MG; Claassen JA
J Am Geriatr Soc; 2010 Feb; 58(2):409-10. PubMed ID: 20370881
[No Abstract] [Full Text] [Related]
40. Orthostatic hypotension is associated with more severe hypertension in elderly autonomous diabetic patients from the French Gerodiab study at inclusion.
Bouhanick B; Meliani S; Doucet J; Bauduceau B; Verny C; Chamontin B; Le Floch JP;
Ann Cardiol Angeiol (Paris); 2014 Jun; 63(3):176-82. PubMed ID: 24958527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
